Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A04809 | 33498410 | J Clin Med | Hepatokines as a Molecular Transducer of Exercise. | 2021 | Details |
| A04810 | 33498329 | Int J Environ Res Public Health | Gender Differences in the Relationships among Metabolic Syndrome and Various Obesity-Related Indices with Nonalcoholic Fatty Liver Disease in a Taiwanese Population. | 2021 | Details |
| A04811 | 33498326 | Cells | Role of Chitinase 3-Like 1 Protein in the Pathogenesis of Hepatic Insulin Resistance in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A04812 | 33497819 | Biochim Biophys Acta Mol Basis Dis | Non-coding RNA crosstalk with nuclear receptors in liver disease. | 2021 | Details |
| A04814 | 33497019 | Liver Int | Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis. | 2021 | Details |
| A04815 | 33496858 | J Gastroenterol | Comorbidities and healthcare costs and resource use of patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in the Japan medical data vision database. | 2021 | Details |
| A04816 | 33496855 | Acta Diabetol | Lack of awareness of liver organ damage in patients with type 2 diabetes. | 2021 | Details |
| A04817 | 33495844 | Mol Med Rep | Effects of renalase deficiency on liver fibrosis markers in a nonalcoholic steatohepatitis mouse model. | 2021 | Details |
| A04818 | 33494735 | BMC Complement Med Ther | Yellow loosestrife (Lysimachia vulgaris var. davurica) ameliorates liver fibrosis in db/db mice with methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis. | 2021 | Details |
| A04819 | 33494361 | J Clin Med | Referral Patterns for Patients with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A04820 | 33494295 | Cells | Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways. | 2021 | Details |
| A04821 | 33493692 | Clin Gastroenterol Hepatol | Trends in the Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in the United States, 2011-2018. | 2021 | Details |
| A04822 | 33493657 | Pharmacol Res | Baicalin and the liver-gut system: Pharmacological bases explaining its therapeutic effects. | 2021 | Details |
| A04824 | 33493297 | Clin Infect Dis | Hepatic Steatosis Associated With Exposure to Elvitegravir and Raltegravir. | 2021 | Details |
| A04825 | 33493235 | PLoS One | Site-specific risk of colorectal neoplasms in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2021 | Details |
| A04826 | 33492571 | Mol Biol Rep | Association of xenobiotic-metabolizing enzymes (GSTM1 and GSTT 1), and pro-inflammatory cytokines (TNF-α and IL-6) genetic polymorphisms with non-alcoholic fatty liver disease. | 2021 | Details |
| A04827 | 33492440 | Eur J Pediatr | The triglycerides and glucose index is strongly associated with hepatic steatosis in children with overweight or obesity. | 2021 | Details |
| A04828 | 33491665 | JCI Insight | Discordant hepatic fatty acid oxidation and triglyceride hydrolysis leads to liver disease. | 2021 | Details |
| A04829 | 33491528 | J Diet Suppl | The Effects of Vitamin E, Silymarin and Carnitine on the Metabolic Abnormalities Associated with Nonalcoholic Liver Disease. | 2021 | Details |
| A04830 | 33491316 | Obesity (Silver Spring) | Fecal Fungi Dysbiosis in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A04831 | 33490936 | JHEP Rep | Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis. | 2020 | Details |
| A04832 | 33490935 | JHEP Rep | (13C)-Methacetin breath test provides evidence of subclinical liver dysfunction linked to fat storage but not lifestyle. | 2020 | Details |
| A04833 | 33490737 | Hepatoma Res | Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease. | 2021 | Details |
| A04834 | 33490623 | JGH Open | Assessment of health-related quality of life and health utilities in Australian patients with cirrhosis. | 2020 | Details |
| A04835 | 33490615 | JGH Open | Seroprevalence of Helicobacter pylori and its association with metabolic syndrome in a rural community of Bangladesh. | 2020 | Details |
| A04836 | 33490240 | Biomed Res Int | Association between Triglyceride-Glucose Index and Type 2 Diabetes Mellitus in the Japanese Population: A Secondary Analysis of a Retrospective Cohort Study. | 2020 | Details |
| A04839 | 33488526 | Front Endocrinol (Lausanne) | Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat. | 2021 | Details |
| A04840 | 33488295 | Mediators Inflamm | Associations among Dietary Omega-3 Polyunsaturated Fatty Acids, the Gut Microbiota, and Intestinal Immunity. | 2021 | Details |
| A04841 | 33487302 | Clin Nutr ESPEN | Dietary polyphenols and the odds of non-alcoholic fatty liver disease: A case-control study. | 2020 | Details |
| A04842 | 33487290 | Clin Nutr ESPEN | The association between dietary antioxidant index (DAI) and nonalcoholic fatty liver disease (NAFLD) onset; new findings from an incident case-control study. | 2020 | Details |
| A04843 | 33486773 | Hepatology | Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus Statement. | 2021 | Details |
| A04844 | 33486695 | Arch Pharm Res | Inhibition of hyaluronan synthesis by 4-methylumbelliferone ameliorates non-alcoholic steatohepatitis in choline-deficient L-amino acid-defined diet-induced murine model. | 2021 | Details |
| A04845 | 33486379 | Comput Biol Med | A meta-analysis of comorbidities in COVID-19: Which diseases increase the susceptibility of SARS-CoV-2 infection? | 2021 | Details |
| A04846 | 33486083 | Clin Gastroenterol Hepatol | Weight Loss and Weight Regain in Usual Clinical Practice: Results From the TARGET-NASH Observational Cohort. | 2021 | Details |
| A04849 | 33485064 | Biomed Pharmacother | Crosstalk between PPARs and gut microbiota in NAFLD. | 2021 | Details |
| A04851 | 33484089 | Andrology | Fatty liver index is associated with the risk of testosterone deficiency in aging men without metabolic syndrome. | 2021 | Details |
| A04853 | 33482185 | Life Sci | Beinaglutide shows significantly beneficial effects in diabetes/obesity-induced nonalcoholic steatohepatitis in ob/ob mouse model. | 2021 | Details |
| A04854 | 33482026 | Aliment Pharmacol Ther | Cross-linkage between bacterial taxonomy and gene functions: a study of metagenome-assembled genomes of gut microbiota in adult non-alcoholic fatty liver disease. | 2021 | Details |
| A04855 | 33481379 | Am J Gastroenterol | Childhood and Adulthood Passive Smoking and Nonalcoholic Fatty Liver in Midlife: A 31-year Cohort Study. | 2021 | Details |
| A04856 | 33479799 | Eur J Pediatr | Pulmonary function test abnormalities in children and adolescents with non-alcoholic fatty liver disease. | 2021 | Details |
| A04857 | 33479589 | Diabetol Int | Improved insulin sensitivity with sodium-glucose cotransporter 2 inhibitor treatment in a patient with slowly progressive type 1 diabetes mellitus with metabolic syndrome: a case report. | 2020 | Details |
| A04858 | 33479187 | J Obes Metab Syndr | Anti-Obesity Effects of Artemisia annua Extract in Zucker Fatty Rats and High-Fat Diet Sprague Dawley Rats through Upregulation of Uncoupling Protein 1. | 2021 | Details |
| A04859 | 33479072 | Clin Med (Lond) | Image of the month: Mauriac variant: a rare complication of poorly controlled diabetes. | 2021 | Details |
| A04860 | 33478287 | Scand J Gastroenterol | Low serum vitamin D level associated with incident advanced liver disease in the general population - a prospective study. | 2021 | Details |
| A04861 | 33477939 | Microorganisms | Fecal Microbiota Transplant from Human to Mice Gives Insights into the Role of the Gut Microbiota in Non-Alcoholic Fatty Liver Disease (NAFLD). | 2021 | Details |
| A04862 | 33477873 | Biomedicines | Extracellular Vesicles as Drivers of Non-Alcoholic Fatty Liver Disease: Small Particles with Big Impact. | 2021 | Details |
| A04863 | 33477579 | J Clin Med | Association of NAFLD and Insulin Resistance with Non Metastatic Bladder Cancer Patients: A Cross-Sectional Retrospective Study. | 2021 | Details |
| A04865 | 33476465 | Clin Transl Sci | Critical need for pharmacologic treatment options in NAFLD: A pediatric perspective. | 2021 | Details |
| A04866 | 33476308 | J Clin Invest | Lipid-induced endothelial vascular cell adhesion molecule 1 promotes nonalcoholic steatohepatitis pathogenesis. | 2021 | Details |
| A04867 | 33475584 | J Pak Med Assoc | Association of apoptotic marker cytokeratin18 with blood pressure in nonalcoholic fatty liver disease patients. | 2020 | Details |
| A04868 | 33475559 | J Pak Med Assoc | Non-alcoholic fatty liver disease: A real threat in Pakistan. | 2020 | Details |
| A04869 | 33474981 | AJR Am J Roentgenol | Utility of Multiparametric CT for Identification of High-Risk NAFLD. | 2021 | Details |
| A04870 | 33474802 | Pharmacol Res Perspect | Dexmedetomidine ameliorates high-fat diet-induced nonalcoholic fatty liver disease by targeting SCD1 in obesity mice. | 2021 | Details |
| A04871 | 33474638 | Eur J Nutr | Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study. | 2021 | Details |
| A04872 | 33473004 | Zhong Nan Da Xue Xue Bao Yi Xue Ban | Progress in the study on innate immunity and non-alcohol fatty liver disease. | 2020 | Details |
| A04873 | 33472102 | Acta Biomater | How histopathologic changes in pediatric nonalcoholic fatty liver disease influence in vivo liver stiffness. | 2021 | Details |
| A04874 | 33471632 | Am J Physiol Gastrointest Liver Physiol | Bacterial and eukaryotic extracellular vesicles and nonalcoholic fatty liver disease: new players in the gut-liver axis? | 2021 | Details |
| A04876 | 33470903 | Am J Physiol Gastrointest Liver Physiol | GCSF deficiency attenuates nonalcoholic fatty liver disease through regulating GCSFR-SOCS3-JAK-STAT3 pathway and immune cells infiltration. | 2021 | Details |
| A04877 | 33470860 | Expert Opin Investig Drugs | A perspective on RNA interference-based therapeutics for metabolic liver diseases. | 2021 | Details |
| A04878 | 33470710 | Eur J Gastroenterol Hepatol | Sleep disruption in nonalcoholic fatty liver disease: What is the role of lifestyle and diet? | 2021 | Details |
| A04879 | 33470379 | Arq Bras Cir Dig | BYPASS VS. SLEEVE AND ITS EFFECTS IN NON-ALCOHOLIC FATTY LIVER DISEASE: WHAT IS THE BEST TECHNIQUE? | 2021 | Details |
| A04880 | 33469809 | Dig Dis Sci | Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis. | 2021 | Details |
| A04881 | 33468357 | Ultrasound Med Biol | Non-invasive Assessment of Liver Fat in ob/ob Mice Using Ultrasound-Induced Thermal Strain Imaging and Its Correlation with Hepatic Triglyceride Content. | 2021 | Details |
| A04882 | 33468321 | Trends Pharmacol Sci | Triglycerides in Nonalcoholic Fatty Liver Disease: Guilty Until Proven Innocent. | 2021 | Details |
| A04883 | 33467660 | Int J Mol Sci | Common Transcriptional Program of Liver Fibrosis in Mouse Genetic Models and Humans. | 2021 | Details |
| A04884 | 33467546 | Int J Mol Sci | Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis. | 2021 | Details |
| A04885 | 33467114 | Diagnostics (Basel) | Prediction of Nonalcoholic Fatty Liver Disease Using Noninvasive and Non-Imaging Procedures in Japanese Health Checkup Examinees. | 2021 | Details |
| A04886 | 33466889 | Metabolites | Two Metabolomics Phenotypes of Human Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease According to Fibrosis Severity. | 2021 | Details |
| A04887 | 33465844 | Clin Mol Hepatol | Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis. | 2021 | Details |
| A04888 | 33465519 | Mol Metab | Hypoxia-inducible lipid droplet-associated induces DGAT1 and promotes lipid storage in hepatocytes. | 2021 | Details |
| A04889 | 33465483 | Clin Gastroenterol Hepatol | NAFLD Cirrhosis Is Rising Among Childbearing Women and Is the Most Common Cause of Cirrhosis in Pregnancy. | 2021 | Details |
| A04890 | 33465383 | Complement Ther Med | Effects of artichoke on blood pressure: A systematic review and meta-analysis. | 2021 | Details |
| A04891 | 33464948 | Circ Heart Fail | Extracardiac Abnormalities of Preload Reserve: Mechanisms Underlying Exercise Limitation in Heart Failure with Preserved Ejection Fraction, Autonomic Dysfunction, and Liver Disease. | 2021 | Details |
| A04892 | 33464703 | Diabetes Obes Metab | Combined exenatide and dapagliflozin has no additive effects on reduction of hepatocellular lipids despite better glycaemic control in patients with type 2 diabetes mellitus treated with metformin: EXENDA, a 24-week, prospective, randomized, placebo-controlled pilot trial. | 2021 | Details |
| A04893 | 33464700 | Kaohsiung J Med Sci | Herp knockout protects against nonalcoholic fatty liver disease in mice on a high fat diet. | 2021 | Details |
| A04894 | 33464677 | Diabetes Obes Metab | Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review. | 2021 | Details |
| A04895 | 33464363 | Eur J Nutr | Relevance of fructose intake in adolescence for fatty liver indices in young adulthood. | 2021 | Details |
| A04896 | 33461969 | BMJ | Management of non-alcoholic fatty liver disease. | 2021 | Details |
| A04897 | 33461965 | Gut | Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial. | 2021 | Details |
| A04898 | 33460786 | Mol Metab | Imaging biomarkers of NAFLD, NASH, and fibrosis. | 2021 | Details |
| A04899 | 33460628 | Biochem Pharmacol | Prenatal dexamethasone exposure induces nonalcoholic fatty liver disease in male rat offspring via the miR-122/YY1/ACE2-MAS1 pathway. | 2021 | Details |
| A04901 | 33460567 | Lancet Gastroenterol Hepatol | Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis. | 2021 | Details |
| A04902 | 33460351 | Scand J Gastroenterol | Nonalcoholic fatty liver disease and the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis: the hidden danger. | 2021 | Details |
| A04903 | 33458794 | Metabolomics | Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis. | 2021 | Details |
| A04904 | 33457424 | J Diabetes Res | Effects of Sodium-Glucose Cotransporter 2 Inhibition on Glucose Metabolism, Liver Function, Ascites, and Hemodynamics in a Mouse Model of Nonalcoholic Steatohepatitis and Type 2 Diabetes. | 2020 | Details |
| A04905 | 33457399 | Can J Gastroenterol Hepatol | Nonalcoholic Fatty Liver Disease-Related Chronic Kidney Disease. | 2020 | Details |
| A04906 | 33456595 | J Med Life | Transgenerational Effects of Traumatic Historical Events on the Incidence of Metabolic Syndrome/ Nonalcoholic Fatty Liver Disease in the Romanian Population. | 2021 | Details |
| A04907 | 33455863 | Trends Endocrinol Metab | Role of Macrophages in the Endocrine System. | 2021 | Details |
| A04908 | 33454241 | J Clin Lipidol | Interrogation of selected genes influencing serum LDL-Cholesterol levels in patients with well characterized NAFLD. | 2020 | Details |
| A04913 | 33453067 | Liver Int | From NAFLD to MAFLD: Nurse and allied health perspective. | 2021 | Details |
| A04915 | 33450482 | Biochem Biophys Res Commun | Hypoxia-inducible factor-2 promotes liver fibrosis in non-alcoholic steatohepatitis liver disease via the NF-κB signalling pathway. | 2021 | Details |
| A04916 | 33450094 | J Physiol | Exposure to high fructose corn syrup during adolescence in the mouse alters hepatic metabolism and the microbiome in a sex-specific manner. | 2021 | Details |
| A04917 | 33449950 | PLoS One | Palmitate induces fat accumulation via repressing FoxO1-mediated ATGL-dependent lipolysis in HepG2 hepatocytes. | 2021 | Details |
| A04918 | 33449917 | Endocr Connect | Pathophysiology of NASH in endocrine diseases. | 2021 | Details |
| A04920 | 33449180 | Eur Radiol | CNN color-coded difference maps accurately display longitudinal changes in liver MRI-PDFF. | 2021 | Details |
| A04921 | 33448929 | J Med Internet Res | Digital Intervention With Lifestyle Coach Support to Target Dietary and Physical Activity Behaviors of Adults With Nonalcoholic Fatty Liver Disease: Systematic Development Process of VITALISE Using Intervention Mapping. | 2021 | Details |
| A04922 | 33447525 | J Clin Transl Hepatol | Skeletal Muscle Dysfunction in the Development and Progression of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A04923 | 33447519 | J Clin Transl Hepatol | Association of TCF7L2 rs7903146 Gene Polymorphism with the Risk of NAFLD and CAD in the Chinese Han Population. | 2020 | Details |
| A04924 | 33447122 | Clin Med Insights Endocrinol Diabetes | Oral GLP1 Analog: Where Does the Tide Go? | 2020 | Details |
| A04925 | 33446707 | Sci Rep | The potential ameliorative impacts of cerium oxide nanoparticles against fipronil-induced hepatic steatosis. | 2021 | Details |